David M. Ashley

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

Amar Gajjar, Murali Chintagumpala, David M. Ashley et al. · The Lancet Oncology · 2006 · 935 citations

Neuro-oncology, Risk-adapted Craniospinal Radiotherapy, Oncology +5

Recurrent Glioblastoma Treated with Recombinant Poliovirus

Annick Desjardins, Matthias Gromeier, James E. Herndon et al. · New England Journal of Medicine · 2018 · 768 citations · Full text

Genomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations

Margaret C. Thompson, Christine Fuller, Twala L. Hogg et al. · Journal of Clinical Oncology · 2006 · 669 citations · Full text

Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors

David M. Ashley, Brenda Faiola, Smita K. Nair et al. · The Journal of Experimental Medicine · 1997 · 444 citations · Full text

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.

H. S. Friedman, R E McLendon, Tracy Kerby et al. · Journal of Clinical Oncology · 1998 · 418 citations